United Therapeutics reported $961.2M in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amarin AMRN:US USD 240.5M 12.5M
Ardelyx ARDX:US USD 84.31M 23.34M
Baxter International BAX:US USD 1.72B 117M
Bayer BAYN:GR EUR 5.17B 810M
Biocryst Pharmaceuticals BCRX:US USD 304.77M 156.42M
Biogen BIIB:US USD 3.42B 256.3M
Biomarin Pharmaceutical BMRN:US USD 724.53M 36.98M
Emergent Biosolutions EBS:US USD 642.6M 401.7M
Esperion Therapeutics ESPR:US USD 124.78M 34.62M
Gilead Sciences GILD:US USD 7.63B 2.93B
GlaxoSmithKline GSK:LN GBP 3.72B 117M
Halozyme Therapeutics HALO:US USD 234.2M 87.04M
Insmed INSM:US USD 1.07B 659.4M
Intercept Pharmaceuticals ICPT:US USD 50.52M 62.68M
Intra Cellular Therapies ITCI:US USD 148.61M 13.26M
Lexicon Pharmaceuticals LXRX:US USD 46.34M 27.51M
Moderna Inc MRNA:US USD 3.2B 178M
Omeros OMER:US USD 11.01M 134.52M
Ptc Therapeutics PTCT:US USD 279.83M 175.41M
Regeneron Pharmaceuticals REGN:US USD 14.33B 10.84B
Sangamo Biosciences SGMO:US USD 100.44M 5.87M
Sarepta Therapeutics SRPT:US USD 966.78M 71.85M
Seattle Genetics SGEN:US USD 319.94M 42.66M
Teva Pharmaceutical TEVA:IT USD 2.8B 576M
United Therapeutics UTHR:US USD 961.2M 5.6M
Vertex Pharmaceuticals VRTX:US USD 10.78B 1.61B